[1]
|
Bombardieri E,Aktolun C,Baum RP,et al.67Ga scintigraphy:procedure guidelines for tumor imaging[J].Eur J Nucl Med Mol Imaging,2003,30(12):125-131. |
[2]
|
Momose M,Sone S,Maruyama Y,et al.Performance of degree of accumulation with 201T1-SPECT in 13 cases of lung cancer smaller than 2 cm[J].Nippon Igaku Hoshasen Gakkai Zasshi,2000,60(12):699-701. |
[3]
|
Nosotti M,Santambrogio L,Gasparini M,et al.Role of 99nfTchexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer[J].Chest,2002,122(4):1361-1364. |
[4]
|
Furuta M,Nozaki M,Kawashima M,et al.99nfTc-MIBI seintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy[J].Eur J Nucl Med Mol Imaging,2003,30(7):982-987. |
[5]
|
黄建敏,曲雁,潘莉萍.恶性骨肿瘤多药耐药的99mTc-MIBI体层显像研究[J].国外医学:放射医学核医学分册,2005,29(4):169-170.
|
[6]
|
Kinuya S,Bai J,Shiba K,et al.99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells[J].Ann of Nucl Med,2006,20(1):29-34. |
[7]
|
Akgun A,Cok G,Karapolat I,et al.Tc-99mMIBI SPECT in prediction of prognosis in patients with small cell lung cancer[J].Ann of Nucl Med,2006,20(4):269-275. |
[8]
|
Yuksel M,Cermik TF,Doganay L,et al.99mTc-MIBI SPECT in nonsmall cell lung cancer in relationship with Pgp and prognosis[J].Eur J Nucl Med Mol Imaging,2002,29(7):876-881. |
[9]
|
陈刚,王荣福.核医学肿瘤乏氧显像的进展[J].北京大学学报:医学版,2006,38(3):335-336.
|
[10]
|
Imahashi K,Morishita K,Kusuoka H,et al.Kinetics of a putative hypoxic tracer 99mTc-HL91,in nonmoxic,hypoxic,ischemic,and stunned myocardiurn[J]J Nuel Med,2000,41(6):1102-1107. |
[11]
|
邓波,肖欢,陈小凤,等.核素乏氧显像和亲肿瘤显像及CT检查诊断肺癌的对比研究[J].中国医师杂志,2005,7(12):1641-1642.
|
[12]
|
Suzuki T,Nakamura K,Kawase T,et al.Monitoring of response to radiation therapy for human tumor xenografts using 99mTc-HL91(4,9-diaza-3,3,10,10-tetramethyldodeean-2,11-dione dioxime)[J].Ann Nuel Med,2003,17(2):131-138. |
[13]
|
Li L,Yu J,Xing L,et al.Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in non small cell lung cancer[J].Am J Clin Oncol,2006,29(6):628-633. |
[14]
|
Coerres GW,Kamel E,Seifert B,et al.Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system[J].J Nucl Med,2002,43(11):1469-1475. |
[15]
|
Lardinois D,Weder W,Hany TF,et al.Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography[J].N Engl J Med,2003,348(25):2500-2507. |
[16]
|
Hany TF,Steinert HC,Goerres GW,et al.PET diagnostic accuracy:improvement with in-line PET-CT system:initial resuhs[J].Radiology,2002,225(2):575-581. |
[17]
|
Antoeh G,Stattaus J,Nemat AT,et al.Non-small cell lung cancer:dual-modality PET/CT in preoterative staging[J].Radiology,2003,229(2):526-533. |
[18]
|
Keidar Z,Haim N,Guralnik L,et al.PET/CT using 18F-FDG in suspected lung cancer recurrence:diagnostic value and impact on patient management[J].J Nucl Med,2004,45(10):1640-1646. |
[19]
|
Nahmias C,Hanna WT,Wahl LM,et al.Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT[J].J Nucl Med,2007,48(5):744-751. |
[20]
|
Blum J,Handmaker H,Lister-James J,et al.A multicenter trial with a somatostatin analog (99m) Tc depreotide in the evaluation of solitary pulmonary nodules[J].Chest,2000,117(5):1232-1238. |
[21]
|
Bradley J,Thorstad WL,Mutic S,et al.Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer[J].Int Radiat Oncol Biol Phys,2004,59(1):78-86. |